The shingles vaccine in Singapore will be subsidised up to 75 per cent for seniors aged 60 and above and younger adults with ...

Starting from September 2025, eligible Singaporeans and permanent residents will be able to receive means-tested subsidies of up to 75 percent for Shingrix, the only vaccine currently approved by the ...

MediSave can be used to pay for the cost of the vaccine after subsidies from 2026. Read more at straitstimes.com.

Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health Minister Ong Ye Kung.

The shingles vaccine is already recommended for older adults to prevent the rash and its painful complications. But new ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...